Solarvest BioEnergy Inc. announce that Edward J. Brennan, Jr., M.D., FACS, has accepted invitation to become a member Solarvest's Board of Directors. Dr. Edward J. Brennan is President of FSD Pharma BioSciences Division and has more than 25 years of experience in leadership roles at major pharmaceutical companies and clinical research organizations. He is an accomplished biophar-maceutical executive with a proven track record in FDA submissions and drug development. Dr. Brennan has extensive experience in all phases of clinical development across multiple therapeutic areas. As a Medical Director with Wyeth-Ayerst Research and GlaxoSmithKline, he led teams through ten IND applications and advanced multiple compounds from pre-candidate selection (proof of concept) through clinical trial management and approval. At GSK, he was also responsible for coordinating all clinical activities for external partners within its Center of Excellence in External Drug Discovery. He next founded IndiPharm, a full-service global CRO, that was eventually acquired by Velocity Fund Partners.